Related Experiment Video
Updated: Jun 11, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
The NSD3L histone methyltransferase regulates cell cycle and cell invasion in breast cancer cells
Zhangle Zhou1, Rune Thomsen, Søren Kahns
1Department of Human Genetics, Aarhus University, Denmark.
Abstract:
NSD3/WHSC1L1 histone methyltransferase gene aberrations are observed in leukemia and in breast and lung carcinomas, suggesting that NSD3 is implicated in carcinogenesis. In this study we examined in human breast cancer cells the NSD3L isoform which contains the catalytic histone methyltransferase SET-domain. siRNA directed depletion of NSD3L followed by genome-wide microarray analysis identified NSD3L regulated genes which could be functionally linked to cellular signaling pathways such as cell growth, cell cycle, cell motility, transcription, and apoptosis. Notably up-regulated genes are the cell cycle regulators E2F2 and Arl2. In accordance with a function of NSD3L in cell cycle regulation NSD3L depletion resulted in an increase in the number of cells in the S and G2/M cell cycle phases. Moreover, NSD3L depletion increased the invasiveness of MDA-MB-231 breast cancer cells indicating that NSD3L normally restrain cellular metastatic potential. Together the presented data indicates that NSD3L is a candidate tumor suppressor.
Insights
The NSD3L histone methyltransferase acts as a tumor suppressor in breast cancer. Its depletion promotes cell cycle progression and increases cancer cell invasiveness, suggesting a role in restraining metastatic potential.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Aberrations in the NSD3 (WHSC1L1) histone methyltransferase gene are linked to various cancers, including leukemia, lung, and breast carcinomas.
- This suggests a potential role for NSD3 in the process of carcinogenesis.
Purpose of the Study:
- To investigate the function of the NSD3L isoform, which possesses the catalytic SET-domain, in human breast cancer cells.
- To identify genes regulated by NSD3L and elucidate its role in cellular signaling pathways relevant to cancer.
Main Methods:
- Utilized siRNA-mediated depletion of NSD3L in human breast cancer cells.
- Performed genome-wide microarray analysis to identify NSD3L-regulated genes.
- Assessed cell cycle progression and cellular invasiveness following NSD3L depletion.
Main Results:
- Identified NSD3L-regulated genes involved in cell growth, cell cycle, cell motility, transcription, and apoptosis.
- Observed up-regulation of cell cycle regulators E2F2 and Arl2 upon NSD3L depletion.
- NSD3L depletion led to increased cell populations in S and G2/M phases and enhanced invasiveness of MDA-MB-231 cells.
Conclusions:
- NSD3L plays a significant role in regulating cell cycle progression and restraining cellular metastatic potential.
- The presented data strongly suggest that NSD3L functions as a tumor suppressor in breast cancer.
Related Concept Videos
Inhibition of Cdk Activity
Abnormal Proliferation
Negative Regulator Molecules
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Cells Coordinate Growth and Proliferation
Epigenetic Regulation
X-chromosome...

